These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 8344359

  • 1. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides.
    Kyburz D, Aichele P, Speiser DE, Hengartner H, Zinkernagel RM, Pircher H.
    Eur J Immunol; 1993 Aug; 23(8):1956-62. PubMed ID: 8344359
    [Abstract] [Full Text] [Related]

  • 2. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
    Prévost-Blondel A, Zimmermann C, Stemmer C, Kulmburg P, Rosenthal FM, Pircher H.
    J Immunol; 1998 Sep 01; 161(5):2187-94. PubMed ID: 9725210
    [Abstract] [Full Text] [Related]

  • 3. [Viral antigen induced autoimmunity: an animal model for diabetes mellitus type I].
    Hengartner H.
    Verh Dtsch Ges Pathol; 1994 Sep 01; 78():177-9. PubMed ID: 7533982
    [Abstract] [Full Text] [Related]

  • 4. Homeostatic regulation of CD8+ T cells after antigen challenge in the absence of Fas (CD95).
    Zimmermann C, Rawiel M, Blaser C, Kaufmann M, Pircher H.
    Eur J Immunol; 1996 Dec 01; 26(12):2903-10. PubMed ID: 8977284
    [Abstract] [Full Text] [Related]

  • 5. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
    von Herrath M, Holz A.
    J Autoimmun; 1997 Jun 01; 10(3):231-8. PubMed ID: 9218748
    [Abstract] [Full Text] [Related]

  • 6. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
    von Herrath MG, Coon B, Lewicki H, Mazarguil H, Gairin JE, Oldstone MB.
    J Immunol; 1998 Nov 01; 161(9):5087-96. PubMed ID: 9794447
    [Abstract] [Full Text] [Related]

  • 7. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
    Cesson V, Stirnemann K, Robert B, Luescher I, Filleron T, Corradin G, Mach JP, Donda A.
    Clin Cancer Res; 2006 Dec 15; 12(24):7422-30. PubMed ID: 17189415
    [Abstract] [Full Text] [Related]

  • 8. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen.
    Pircher H, Bürki K, Lang R, Hengartner H, Zinkernagel RM.
    Nature; 1989 Nov 30; 342(6249):559-61. PubMed ID: 2573841
    [Abstract] [Full Text] [Related]

  • 9. Preferential usage of V alpha 4 and V beta 10 T cell receptor genes by lymphocytic choriomeningitis virus glycoprotein-specific H-2Db-restricted cytotoxic T cells.
    Aebischer T, Oehen S, Hengartner H.
    Eur J Immunol; 1990 Mar 30; 20(3):523-31. PubMed ID: 2138558
    [Abstract] [Full Text] [Related]

  • 10. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection.
    Byrne JA, Oldstone MB.
    J Immunol; 1986 Jan 30; 136(2):698-704. PubMed ID: 2416821
    [Abstract] [Full Text] [Related]

  • 11. Involvement of both T cell receptor V alpha and V beta variable region domains and alpha chain junctional region in viral antigen recognition.
    Brändle D, Bürki K, Wallace VA, Rohrer UH, Mak TW, Malissen B, Hengartner H, Pircher H.
    Eur J Immunol; 1991 Sep 30; 21(9):2195-202. PubMed ID: 1716213
    [Abstract] [Full Text] [Related]

  • 12. Clonal deletion of major histocompatibility complex class I-restricted CD4+CD8+ thymocytes in vitro is independent of the CD95 (APO-1/Fas) ligand.
    Müller KP, Mariani SM, Matiba B, Kyewski B, Krammer PH.
    Eur J Immunol; 1995 Oct 30; 25(10):2996-9. PubMed ID: 7589104
    [Abstract] [Full Text] [Related]

  • 13. CD2-deficient mice generate virus-specific cytotoxic T lymphocytes upon infection with lymphocytic choriomeningitis virus.
    Evans CF, Rall GF, Killeen N, Littman D, Oldstone MB.
    J Immunol; 1993 Dec 01; 151(11):6259-64. PubMed ID: 7902375
    [Abstract] [Full Text] [Related]

  • 14. Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins.
    Kyburz D, Speiser DE, Battegay M, Hengartner H, Zinkernagel RM.
    Eur J Immunol; 1993 Jul 01; 23(7):1540-5. PubMed ID: 8325330
    [Abstract] [Full Text] [Related]

  • 15. Protective immunity from naive CD8+ T cells activated in vitro with MHC class I binding immunogenic peptides and IL-2 in the absence of specialized APCs.
    Hauser C, Zipprich F, Leblond I, Wirth S, Hügin AW.
    J Immunol; 1999 Jul 01; 163(1):330-6. PubMed ID: 10384132
    [Abstract] [Full Text] [Related]

  • 16. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells.
    Moskophidis D, Lechner F, Pircher H, Zinkernagel RM.
    Nature; 1993 Apr 22; 362(6422):758-61. PubMed ID: 8469287
    [Abstract] [Full Text] [Related]

  • 17. Virus-specific cytotoxic T cell-mediated lysis of lymphocytes in vitro and in vivo.
    Kyburz D, Speiser DE, Aebischer T, Hengartner H, Zinkernagel RM.
    J Immunol; 1993 Jun 01; 150(11):5051-8. PubMed ID: 7684417
    [Abstract] [Full Text] [Related]

  • 18. The lack of CD8 alpha cytoplasmic domain resulted in a dramatic decrease in efficiency in thymic maturation but only a moderate reduction in cytotoxic function of CD8+ T lymphocytes.
    Fung-Leung WP, Louie MC, Limmer A, Ohashi PS, Ngo K, Chen L, Kawai K, Lacy E, Loh DY, Mak TW.
    Eur J Immunol; 1993 Nov 01; 23(11):2834-40. PubMed ID: 8223860
    [Abstract] [Full Text] [Related]

  • 19. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation.
    Althage A, Odermatt B, Moskophidis D, Kündig T, Hoffman-Rohrer U, Hengartner H, Zinkernagel RM.
    Eur J Immunol; 1992 Jul 01; 22(7):1803-12. PubMed ID: 1623925
    [Abstract] [Full Text] [Related]

  • 20. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules.
    Hudrisier D, Oldstone MB, Gairin JE.
    Virology; 1997 Jul 21; 234(1):62-73. PubMed ID: 9234947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.